{
    "organizations": [],
    "uuid": "a50281eb31e39c3a630a5b5b298b903633f1cab5",
    "author": "",
    "url": "https://www.reuters.com/article/brief-inovio-pharmaceuticals-parker-inst/brief-inovio-pharmaceuticals-parker-institute-for-cancer-immunotherapy-establish-clinical-development-collaboration-to-evaluate-novel-cancer-immunotherapy-combinations-idUSFWN1P40DM",
    "ord_in_thread": 0,
    "title": "BRIEF-Inovio Pharmaceuticals, Parker Institute For Cancer Immunotherapy Establish Clinical Development Collaboration To Evaluate Novel Cancer Immunotherapy Combinations",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 25 PM / Updated 9 minutes ago BRIEF-Inovio Pharmaceuticals, Parker Institute For Cancer Immunotherapy Establish Clinical Development Collaboration To Evaluate Novel Cancer Immunotherapy Combinations Reuters Staff 1 Min Read \nJan 9 (Reuters) - Inovio Pharmaceuticals Inc: \n* INOVIO PHARMACEUTICALS AND THE PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY ESTABLISH CLINICAL DEVELOPMENT COLLABORATION TO EVALUATE NOVEL CANCER IMMUNOTHERAPY COMBINATIONS \n* INOVIO PHARMACEUTICALS - UNDER AGREEMENT, PARKER INSTITUTE WILL HAVE RESPONSIBILITY FOR CLINICAL STUDY EXECUTION \n* INOVIO PHARMACEUTICALS - WILL PROVIDE FINANCIAL CONTRIBUTIONS IF COâ€˜S PRODUCT(S) STUDIED UNDER COLLABORATION REACHES INITIATION OF PHASE 3 STUDY Source text for Eikon:  ",
    "published": "2018-01-09T15:24:00.000+02:00",
    "crawled": "2018-01-09T15:43:03.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "parker",
        "institute",
        "cancer",
        "immunotherapy",
        "establish",
        "clinical",
        "development",
        "collaboration",
        "evaluate",
        "novel",
        "cancer",
        "immunotherapy",
        "combination",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "inovio",
        "pharmaceutical",
        "inc",
        "inovio",
        "pharmaceutical",
        "parker",
        "institute",
        "cancer",
        "immunotherapy",
        "establish",
        "clinical",
        "development",
        "collaboration",
        "evaluate",
        "novel",
        "cancer",
        "immunotherapy",
        "combination",
        "inovio",
        "pharmaceutical",
        "agreement",
        "parker",
        "institute",
        "responsibility",
        "clinical",
        "study",
        "execution",
        "inovio",
        "pharmaceutical",
        "provide",
        "financial",
        "contribution",
        "co",
        "product",
        "studied",
        "collaboration",
        "reach",
        "initiation",
        "phase",
        "study",
        "source",
        "text",
        "eikon"
    ]
}